Thrombocytopenia and bleeding in veterans with non-hepatitis C-related chronic liver disease

Digestive Diseases and Sciences

Volumn 58, Issue 2, 2013, Pages 562-573

  Hermos, John A ^a,b   Altincatal, Arman ^a   Christian Weber, H ^a,b   Grotzinger, Kelly ^c   Smoot, Kyle J ^a   Cho, Kelly ^a,d   Gagnon, David R ^a,e   Lawler, Elizabeth V ^a,d  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GLAXOSMITHKLINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Chronic liver disease; Hemorrhage; Thrombocytopenia; Veterans

Indexed keywords

ADULT; ARTICLE; BLEEDING; CHRONIC LIVER DISEASE; COHORT ANALYSIS; COLON POLYP; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ESOPHAGUS VARICES; EXCISION; FEMALE; FOLLOW UP; HEALTH CARE SYSTEM; HEMATEMESIS; HEPATITIS C; HEPATORENAL SYNDROME; HOSPITALIZATION; HUMAN; INVASIVE PROCEDURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MELENA; PORTAL HYPERTENSION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UNITED STATES; VETERAN; AGED; CHRONIC DISEASE; FACTUAL DATABASE; GASTROINTESTINAL HEMORRHAGE; INCIDENCE; LIVER DISEASE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX; STATISTICS;

AGED; CHRONIC DISEASE; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEPATITIS C; HUMANS; INCIDENCE; LIVER DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PLATELET COUNT; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; VETERANS;

MLCS; MLOWN;

EID: 84876327307     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2404-0     Document Type: Article

References (25)

1. Giannini EG. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther. 2006;23:1055-1065.
2. Poordad F. Review article: thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther. 2007;26(Suppl 1):5-11.
3. Afdhal N, McHutchison J, Brown R, et al. Review: thrombocytopenia associated with chronic liver disease. J Hepatol. 2008;48:1000-1010.
4. Udell JA, Wang CS, Tinmouth J, et al. Does this patient with liver disease have cirrhosis? JAMA. 2012;307:832-842.
5. Aster R. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest. 1966;45:645-657.
6. Bashour FN, Teran JC, Mullen KD. Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol. 2000;95:2936-2939.
7. Giannini E, Botta F, Borro P, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003;52:1200-1205.
8. Sorensen HT, Thulstrup AM, Mellemkjar L, et al. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. J Clin Epidemiol. 2003;56:88-93.
9. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-231.
10. Peck-Radosavljevic M. Review article: coagulation disorder in chronic liver disease. Aliment Pharmacol Ther. 2007;26(Suppl 1):21-28.
11. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365:147-156.
12. Borowsky SA, Strome S, Lott E. Continued heavy drinking and survival in alcoholic cirrhotics. Gastroenterology. 1981;80:1405-1409.
13. Hermos JA. Drinking by alcoholic cirrhotic patients under medical care: a literature survey. Alcohol: Clin Exp Res. 1984;8:314-318.
14. Jepsen P, Ott P, Andersen PK, Sorensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based study. Hepatology. 2010;51:1675-1682.
15. Vazali E, Aghemo A, Colombo M. A review of the treatment of chronic hepatitis C virus infection in cirrhosis. Clin Ther. 2010;32:2117-2138.
16. Louis KS, Micallef JM, Pimenta JM, Forssen UM. Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review. J Viral Hepatitis. 2011;18:1-7.
17. Lo Re V, Lim JK, Goetz MB, Tate J, Bathulapalli H, Klein MB et al. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Phamacoepidemiol Drug Safety 2011;20:689-699.
18. Pluta A, Gutkowski K, Sawka D. Thrombocytopenia in hepatitic C infection and chronic liver disease. Exp Clin Hepatol. 2009;5:15-19.
19. Roomer R, Hansen BE, Janssen HLA, de Knegt RJ. Thrombocytopenia and the risk of bleeding during treatment with peginterferon alfa and ribavirin for chronic hepatitis C. J Hepatol. 2010;53:455-459.
20. Nachnani JS, Rao GA, Bulchandani D, Pandya PK, Alba LM. Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin. Ann Hematol. 2012;89:121-125.
21. Lin K-H, Hsu P-I, Kin C-K, et al. Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatis C and pretreatment low platelet counts. BMC Gastroenterol. 2012;12:7.
22. McHutchison JG, Dusheiko G, Shiffman ML, et al. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med. 2007;357:2227-2236.
23. Alverex GC, Gomez-Galicia D, Rodriguez-Fragoso L, et al. Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin. Ann Hepatol. 2011;10:458-468.
24. Brown RS Jr. Review article: a pharmacoeconomic analysis of thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther. 2007;26:41-48.
25. Poordad F, Theodore D, Sullivan J, Grotzinger K. Medical resource utilization in healthcare costs in patients with chronic hepatitis C viral infection and thrombocytopenia. J Med Econ. 2011;14:194-206.